Statistical evaluation of absolute change versus responder analysis in clinical trials
Acta Materia Medica · 2022 · 1 (3)
DOI: 10.15212/amm-2022-0020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Materia Medica, 2022. Verfasst von Peijin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham North Carolina. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
In clinical trials, the primary analysis is often either a test of absolute/relative change in a measured outcome or a corresponding responder analysis. Although each of these tests may be reasonable, determining which test is most suitable for a particular research study remains an open question. These tests may require different sample sizes or define different clinically meaningful differences; most importantly, they may lead to different study conclusions. The aim of this study was to compare a typical non-inferiority test using absolute change as the study endpoint to the corresponding responder analysis in terms of sample-size requirements, statistical power, and hypothesis-testing results. From numerical analysis, using absolute change as an endpoint generally requires a larger sample size; therefore, when the sample size is the same, the responder analysis has higher power. The cut-off value and non-inferiority margin are critical and can meaningfully affect whether the two types of endpoints yield conflicting conclusions. Specifically, extreme cut-off values are more likely to yield different conclusions. However, this influence decreases as population variance increases. One important reason for conflicting conclusions is a non-normal population distribution. To eliminate conflicting results, researchers should consider the population distribution and cut-off value selection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham North Carolina.
- Department of Cardiology, Duke Health System, Durham, North Carolina.
- Department of Psychiatry and Behavioral Sciences, Duke Health System, Durham, North Carolina.
Förderung
- NCATS NIH HHS
Zitieren
APA
Wang, P., Peskoe, S., Byrd, R., Smith, P., Breslin, R., & Chow, S. C. (2022). Statistical evaluation of absolute change versus responder analysis in clinical trials. Acta Materia Medica, 1(3). https://doi.org/10.15212/amm-2022-0020
Vancouver
Wang P, Peskoe S, Byrd R, Smith P, Breslin R, Chow SC. Statistical evaluation of absolute change versus responder analysis in clinical trials. Acta Materia Medica. 2022;1(3). doi:10.15212/amm-2022-0020
BibTeX
@article{Wang2022,
author = {Wang, Peijin and Peskoe, Sarah and Byrd, Rebecca and Smith, Patrick and Breslin, Rachel and Chow, Shein-Chung},
title = {Statistical evaluation of absolute change versus responder analysis in clinical trials},
journal = {Acta Materia Medica},
year = {2022},
volume = {1},
number = {3},
doi = {10.15212/amm-2022-0020}
}
EUVIMED